Neurocognitive Impairment in Patients Treated with Protease Inhibitor Monotherapy or Triple Drug Antiretroviral Therapy

BACKGROUND: In patients who remain virologically suppressed in plasma with triple-drug ART a switch to protease inhibitor monotherapy maintains high rates of suppression; however it is unknown if protease inhibitor monotherapy is associated to a higher rate of neurocognitive impairment. METHODS: In...

Descripción completa

Detalles Bibliográficos
Autores principales: Pérez-Valero, Ignacio, González-Baeza, Alicia, Estébanez, Miriam, Montes-Ramírez, María L., Bayón, Carmen, Pulido, Federico, Bernardino, José I., Zamora, Francisco X., Monge, Susana, Gaya, Francisco, Lagarde, María, Rubio, Rafael, Hernando, Asunción, Arnalich, Francisco, Arribas, José R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3723908/
https://www.ncbi.nlm.nih.gov/pubmed/23936029
http://dx.doi.org/10.1371/journal.pone.0069493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3723908/
https://www.ncbi.nlm.nih.gov/pubmed/23936029
http://dx.doi.org/10.1371/journal.pone.0069493

Ejemplares similares